A blood test that sees Alzheimer's risk years ahead
Researchers at the Mass General Brigham Neuroscience Institute pooled six observational studies and clinical trials from North America, Japan, and Australia. That gave them 2,684 older adults with no sign of cognitive impairment when they enrolled, some as early as 2004, followed through 2025 7.
Each person's blood was measured for a marker called phosphorylated tau 217 (p-tau217), and each had a PET brain scan at baseline. About 478 of them eventually developed cognitive impairment 7. Among people with very high p-tau217, the risk was 38% within five years and an estimated 78% within ten, though the ten-year figure rests on substantially less data 7. The results appeared in JAMA and were presented at the Alzheimer's Association International Conference 7.
